Characteristic Total n=9,758 Deathsn(%) p value Male n=3,229 Deathsn(%) Female n=6,530 Deathsn(%)
Age-group (years)   0.008*        
15-29 3,147 45(1.4)   393 4(4.0) 2,754 41(1.5)
30-39 3,967 73(1.8)   1,378 31(2.2) 2,589 42(1.6)
40-49 2,001 47(2.3)   1,069 35(3.3) 932 12(1.3)
50+ 644 16(2.5)   389 9(2.3) 255 7(2.7)
HBsAg status   0.034        
HBsAg +ve 1,950 48(2.5)   721 25(3.5) 1,230 23(1.9)
HBsAg –ve 7,808 133(1.7)   2,508 54(2.2) 5,300 79(1.5)
Liver disease   0.9        
Present 23 0(0.0)   5 0(0.0) 18 0(0.0)
Absent 9,728 181(1.9)   3,220 79(2.5) 6,508 102(1.9)
TB diagnosis   <0.0001        
Present 1,640 55(3.4)   743 30(4.0) 898 25(2.8)
Absent 8,118 126(1.6)   2,486 49(2.0) 5,632 77(1.4)
HIV RNA at baseline (viral copies/mL) 0.06*        
<400 1,267 25(2.0)   408 11(2.7) 859 14(1.6)
400-9,999 1,950 23(1.2)   565 9(1.6) 1,385 14(1.0)
10,000-29,999 1,523 22(1.4)   427 10(2.3) 1,096 12(1.1)
≥30,000 5,019 111(2.2)   1,829 49(2.7) 3,190 62(1.9)
CD4 cell count at baseline (cells/mL) 0.003*        
<200 1,599 24(1.5)   605 7(1.2) 994 17(1.7)
200-499 1,050 4(0.4)   295 1(0.3) 755 3(0.4)
≥500 136 0(0.0)   24 0(0.0) 112 0(0.0)
Period of enrolment <0.0001        
2004-2006 5,920 143(2.4)   1,963 67(3.4) 3,958 76(1.9)
2007-2010 3,838 38(1.0)   1,266 12(0.9) 2,572 26(1.0)
*p values indicate comparison for trend
Table 1: Baseline characteristics and associated deaths among HIV-infected patients in Nigeria, 2004-2010.
Goto home»